II
SNDX icon

Inspire Investing’s Syndax Pharmaceuticals SNDX Stock Holding History

Inspire Investing’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$515K Sell
22,031
-111
-0.5% -$2.41K 0.03% 665
2025
Q4 		$465K Sell
22,142
-6,691
-23% -$117K 0.04% 684
2025
Q3 		$444K Sell
28,833
-14,090
-33% -$184K 0.04% 734
2025
Q2 		$402K Buy
42,923
+15,025
+54% +$165K 0.04% 327
2025
Q1 		$343K Sell
27,898
-2,894
-9% -$40.8K 0.04% 632
2024
Q4 		$407K Buy
30,792
+9,484
+45% +$162K 0.05% 366
2024
Q3 		$410K Buy
21,308
+4,018
+23% +$83K 0.04% 698
2024
Q2 		$355K Buy
17,290
+2,258
+15% +$47.3K 0.04% 406
2024
Q1 		$358K Sell
15,032
-2,748
-15% -$61.3K 0.04% 644
2023
Q4 		$384K Sell
17,780
-3,315
-16% -$51K 0.04% 530
2023
Q3 		$306K Sell
21,095
-7,673
-27% -$145K 0.04% 623
2023
Q2 		$602K Buy
28,768
+2,724
+10% +$56.7K 0.07% 255
2023
Q1 		$550K Buy
26,044
+16,666
+178% +$415K 0.07% 211
2022
Q4 		$239K Buy
+9,378
New +$219K 0.03% 366

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Inspire Investing's SNDX Position: Q1 2026 in Review

Inspire Investing reduced its Syndax Pharmaceuticals (SNDX) stake by 0.5% in Q1 2026, selling an estimated $2.41K and leaving 22,031 shares worth $515K. The position accounts for 0.03% of the portfolio, ranked #665.

Inspire Investing first reported a position in SNDX in Q4 2022 and has held it in 14 quarters since. The position peaked at $602K in Q2 2023. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Inspire Investing held 22,031 shares of Syndax Pharmaceuticals worth $515K as of Q1 2026.
  • Inspire Investing sold 111 Syndax Pharmaceuticals shares in Q1 2026, an estimated $2.41K.
  • Syndax Pharmaceuticals made up 0.03% of Inspire Investing's portfolio in Q1 2026, its #665 holding.
  • Inspire Investing first reported a position in Syndax Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
  • Inspire Investing's Syndax Pharmaceuticals position peaked at $602K in Q2 2023.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.